‘Healthy’ Kids With Obesity Still Face Alarming Disease Risks By Age 30

For years, a reassuring idea has floated through doctor’s offices and dinner-table conversations alike: some children with obesity are basically fine. As long as their blood sugar, blood pressure, and cholesterol look normal, the thinking goes, their weight isn’t really a health problem. It’s an appealing message for families already dealing with weight stigma. But a large new study tracking thousands of Swedish children into adulthood tells a different story.

Even kids with so-called “metabolically healthy obesity,” meaning obesity with no abnormal lab results, face dramatically higher rates of Type 2 diabetes, high blood pressure, and cholesterol problems by age 30 compared to their peers in the general population.

The timing matters. A major commission published in The Lancet recently proposed redefining obesity in a way that would separate “preclinical” obesity, considered low-risk and rarely needing treatment, from “clinical” obesity, defined by excess body fat plus specific health problems. Under that framework, many children with obesity but clean lab results might not qualify for treatment. This new research adds to that debate, suggesting that normal metabolic numbers in childhood are no guarantee of staying healthy.

“Treatment should also be recommended for children with obesity who appear metabolically healthy,” the study’s authors concluded. Their data make a strong case: waiting for blood tests to go wrong before stepping in may mean missing a window that matters.

How Researchers Tracked Metabolically Healthy Obesity Into Adulthood

Researchers at Karolinska Institutet in Stockholm analyzed data from 7,275 children enrolled in Sweden’s national childhood obesity treatment registry, known as BORIS, between 1997 and 2020. These kids ranged in age from 7 to 17 when they started treatment, and all had a full set of health measurements, including blood pressure, fasting blood sugar, liver enzyme levels, and cholesterol, collected within the first three months.

Each child with obesity was matched with five peers from the general Swedish population based on sex, birth year, and home region, creating a comparison group of 35,636 people. Researchers then tracked everyone through Sweden’s national health registries, which capture hospital diagnoses, prescription medications, and deaths. Follow-up continued until participants turned 30, died, left the country, or reached the study’s end date in July 2023. The median follow-up time was about 8.3 years.

Children with obesity were split into two groups. About half, 3,626 kids or 49.8%, qualified as having metabolically healthy obesity, meaning none of their measurements were abnormal at the start. The other half, 3,649 children, had at least one red flag such as elevated blood pressure, high blood sugar, abnormal liver enzymes, or unhealthy cholesterol levels, placing them in the metabolically unhealthy category.

The Disease Risks Behind ‘Normal’ Lab Results

By age 30, the disease rates were stark. Among children originally classified as metabolically healthy with obesity, 9.1% had developed type 2 diabetes. That compares to 16.8% of those in the metabolically unhealthy group and just 0.5% of the general population. For high blood pressure, the numbers were 10.8%, 18.3%, and 3.7%. For cholesterol problems, 5.3% of the metabolically healthy obesity group was affected, versus 12.7% of the unhealthy group and 0.9% of the general population.

Put another way, children who looked metabolically fine at their first obesity treatment visit were still roughly 18 times more likely to develop type 2 diabetes by age 30 than their general population peers. Even so, most children did not develop diabetes by age 30. They were about three times more likely to develop high blood pressure and nearly six times more likely to develop cholesterol problems.

Adjusted rates told the same story. Children with metabolically healthy obesity developed type 2 diabetes at a rate of 36.2 per 10,000 person-years, compared with 2.1 per 10,000 in the general population. For high blood pressure, the rate was 23.2 versus 8.1. For cholesterol problems, 11.4 versus 1.9. All of these differences were statistically significant.

Premature death rates were low across all groups: 0.3% by age 30 for the metabolically healthy obesity group, 0.8% for the unhealthy group, and 0.4% for the general population. The small number of deaths limited what could be drawn from these figures.

Weight Loss Helped Everyone, Regardless of Lab Results

One of the most practical findings came from a subgroup of 2,532 children who received obesity treatment for at least one year. Researchers measured changes in a standardized weight score, adjusted for each child’s age and sex, between the first and last treatment visits.

Children who achieved a meaningful reduction in that score saw dramatically lower disease risks. Their rate of type 2 diabetes dropped by 78% compared to children whose weight increased. High blood pressure risk fell by 44%, and cholesterol problems dropped by 72%. These protective effects held whether a child started out metabolically healthy or unhealthy. Weight loss appeared to benefit both groups to the same degree.

Even more modest results, simply holding steady rather than gaining weight, were tied to real reductions in risk. Children whose weight score barely changed still had about half the risk of type 2 diabetes, high blood pressure, and cholesterol problems compared to those who gained weight.

Why ‘Metabolically Healthy’ May Be a Temporary Label

The study also found that younger children were more likely to appear metabolically healthy. About 60% of children aged 7 to 8 fell into that category, compared with roughly 40% of those aged 13 and older. Metabolic health in childhood obesity may simply reflect an earlier point on a path, a temporary state rather than a lasting characteristic.

Severity of obesity itself was also an independent risk factor. Children with more severe obesity had significantly higher risks of all outcomes, even after accounting for metabolic status. For premature death, the risk tied to more severe obesity was actually higher than the risk tied to unhealthy metabolic markers alone.

Researchers noted that current metabolic markers, while useful, “are not sufficient to discriminate between healthy and unhealthy obesity among children and adolescents with obesity.” They pointed to precision medicine tools as a potential future avenue for identifying children who might truly be at low risk.

When researchers ran additional checks, excluding the 183 individuals who had weight-loss surgery during follow-up or applying stricter thresholds for defining metabolically healthy obesity, the patterns held.

One important caveat: the general population comparison group was not confirmed to be at a healthy weight. Height and weight data were not available for those individuals, meaning the comparison group reflected the full range of body sizes in Sweden. If anything, the true gap between children with obesity and normal-weight peers could be even larger than what the study captured.

The debate over whether obesity itself is a disease, or only becomes one when complications show up, carries real consequences for millions of families. It shapes insurance coverage, school health programs, clinical guidelines, and whether a pediatrician recommends treatment or takes a wait-and-see approach.

The findings point toward earlier action: treating childhood obesity regardless of what early lab results show, because those results appear to offer false reassurance about what lies ahead.

---

Disclaimer: This article is for informational purposes only and is not intended to serve as medical advice, diagnosis, or treatment. The findings summarized here reflect results from a specific observational study and may not apply to all individuals. Readers should not make changes to their health or their child’s health based solely on this information. Always consult a qualified healthcare professional with questions about medical conditions, treatment options, or preventive care.

---